SCHEMBL4962

SCHEMBL4962

CCC[C@]1(O)CC[C@]2(CCN(c3ccc(OCCOC)cc3)C2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RYR2 Q92736 1/20 0.41
FFAR4 Q5NUL3 2/20 0.41
LIPE Q05469 1/20 0.39
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38
CYP3A4 P08684 9/20 0.37
CYP2C19 P33261 4/20 0.37
TSHR P16473 3/20 0.37
ALDH1A1 P00352 7/20 0.37
USP2 O75604 6/20 0.37
HSD17B10 Q99714 4/20 0.37
HPGD P15428 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
MEN1 O00255 3/20 0.37
CYP2C9 P11712 3/20 0.37
KMT2A Q03164 3/20 0.37
CYP1A2 P05177 3/20 0.37
MAPT P10636 3/20 0.36
TAAR1 Q96RJ0 1/20 0.36
MAPK1 P28482 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5485 0.93 RYR2 (0.45) RYR2FFAR4ITGB3ITGA2BCYP3A4
SCHEMBL5639 0.85 S1PR1 (0.41) LIPECYP3A4CYP2C19TSHRALDH1A1
SCHEMBL5614 0.81 LIPE (0.60) FFAR4LIPE
SCHEMBL5651 0.77 LIPE (0.38) LIPEITGB3ITGA2BCYP3A4CYP2C19
SCHEMBL5924 0.76 ITGB3 (0.38) LIPEITGB3ITGA2BCYP3A4CYP2C19
SCHEMBL1589050 0.76 LIPE (0.69) LIPE
SCHEMBL1589049 0.76 LIPE (0.69) LIPE
SCHEMBL5406 0.75 KCNJ1 (0.39) LIPEITGB3ITGA2BCYP3A4CYP2C19
SCHEMBL12058 0.74 LIPE (0.42) LIPEITGB3ITGA2BCYP3A4CYP2C19
SCHEMBL12072 0.73 KCNJ1 (0.36) LIPEITGB3ITGA2BACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed